Article

What We're Reading: Idaho AG Sues Purdue Pharma; Texas Tobacco Law; Healthcare for Undocumented Immigrants

Author(s):

Purdue Pharmaceuticals and the company’s owners have been sued by Idaho’s Attorney General for allegedly contributing to the opioid epidemic; the governor of Texas has signed a bill into law that will raise the state’s minimum age to purchase tobacco and tobacco-related products to 21; California law makers have agreed to a budget deal that will provide healthcare to young, low-income, undocumented immigrants.

Idaho Attorney General Sues Purdue Pharma, Sackler Family

Idaho Attorney General Lawrence Wasden has filed a lawsuit accusing Purdue Pharmaceuticals and the company’s owners, the Sackler family, of profiting off the opioid crisis, according to The Hill. The lawsuit alleges the company misled physicians into prescribing opioids over competing treatments despite the dangers and risks of addiction associated with opioids. Purdue has denied the claims and plans to fight them in court.

Texas Governor Signs Bill to Raise Tobacco Purchasing Age to 21

Texas Governor Greg Abbott has signed a bill into law that will increase the state’s minimum age to purchase tobacco products to 21, CNN reported. The law covers cigarettes, e-cigarettes, and other tobacco-related products. Supporters of the legislation, which will become effective September 1, 2019, believe that increasing the age requirement will reduce the risk of addiction.

California Will Become First State to Offer Healthcare to Undocumented Immigrants

California law makers have agreed to a budget deal that will provide health insurance benefits, through the state’s Medicaid program, to low-income, undocumented immigrants between the ages of 19 to 25, The Hill reported. The program would cost approximately $98 million per year and cover about 90,000 individuals. The budget agreement must first be approved by the full state Legislature before it is officially enacted.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Dan Nardi
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo